| 摘要 |
FIELD: pharmaceutics.SUBSTANCE: group of inventions relates to pharmaceutics and medicine and concerns using ethyl ether of N-phenyl acetyl-L-prolylglycine for activating transcription factor HIF (hypoxia induced factor), as well as method of HIF activating using said factor and method of treating diseases, associated with HIF transcription factor deficiency.EFFECT: group of inventions provides higher body resistance to oxygen supply deficit, which is effective for treatment of hypoxic states of various genesis.3 cl, 1 tbl, 2 ex, 2 dwg |
